Supply Chain

Here are the five latest medical devices or drugs approved by the Food and Drug Administration.

Natco Pharma, an India-based pharmaceutical company, received FDA approval yesterday for its glycopyrrolate oral tablets.

Lupin, a drug company headquartered in Mumbai, recently earned FDA approval for its Amabelz tablets.

After the CDC announced today that nasal spray vaccines are ineffective in children and should not be used, AstraZeneca said it would have to take an $80 million inventory write-down on stocks of its nasal spray vaccine Flumist Quadrivalent, according…

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

St. Jude Medical, a device maker headquartered in St. Paul, Minn., launched new SyncAV cardiac resynchronization therapy software to treat heart failure in patients who do not respond to conventional treatments.

Hartford, Conn.-based Saint Francis Hospital and Medical Center recently received a three-year ultrasound practice accreditation from the American Institute of Ultrasound in Medicine.

The Food and Drug Administration recently approved a new drug made by Miami-based Opko Health.

As prescription drug prices continue to rise, employers are finding greater need to initiate expense saving methods to keep costs controlled.

CytoSorbents, a critical care immunotherapy company based in Monmouth Junction, N.J., is the recipient of a $150,000 phase I Small Business Technology Transfer contract to develop a blood purification technology that may create universal plasma.